Results 291 to 300 of about 1,271,462 (341)

Assessment of Tumor Markers in Renal Transplant Recipients. [PDF]

open access: yesCancer Diagn Progn
Fukae S   +6 more
europepmc   +1 more source

AI-Based Prediction Of Visual Outcomes In Patients With Suprasellar Or Optic Pathway Tumor :A Meta-Analysis Of Neuro-Ophtalmic And MRI Markers

open access: green
Avesta Kowsar   +13 more
openalex   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Tumor markers

Current Problems in Surgery, 1982
Several substances, referred to as tumor markers, are associated with neoplasms development. The specificity of these cancer related substances or antigens depends on their nature (onco-fetal antigens, placental antigens) or on their concentration and physico-chemical forms (hormones, exocrine products, enzymes,...).
H P, Ewing, B D, Newsom, J D, Hardy
openaire   +4 more sources

Gynecologic tumor markers

Seminars in Surgical Oncology, 1990
AbstractThe advent of monoclonal technology has increased the potential utility of antibody‐dependent tumor marker assays in gynecologic oncology. The availability of unlimited quantities of several pure monoclonal antibodies directed against novel epitopes on tumor‐associated antigens has permitted development of highly sensitive assays for serum ...
G J, Olt, A, Berchuck, R C, Bast
openaire   +2 more sources

Tumor Markers in Neuroendocrine Tumors

Digestion, 2000
Most neuroendocrine tumors produce and secrete a multitude of peptide hormones and amines. Some of these substances cause a specific clinical syndrome: carcinoid, Zollinger-Ellison, hyperglycemic, glucagonoma and WDHA syndrome. Specific markers for these syndromes are basal and/or stimulated levels of urinary 5-HIAA, serum or plasma gastrin, insulin ...
K, Oberg, E T, Janson, B, Eriksson
openaire   +3 more sources

Viral Tumor Markers

1987
In diagnostic virology, isolation of viruses by culturing infectious material and serological immunoassays have usually met the clinical needs for: 1. accurate identification of the infectious agent, 2. definition of the state of the disease (acute, convalescence, recovery), 3.
T, Löning, K, Milde
openaire   +3 more sources

[Tumor markers].

Acta medica Austriaca, 2001
Tumour markers are substances developed in or induced by tumour cells and secreted into body fluids in which they can be quantified by non-invasive analyses. The malignant transformation of cells leads to increased concentrations of tumour markers and thus they can indicate malignant diseases.
W, Fiebiger, C, Wiltschke
openaire   +3 more sources

TUMOR MARKERS

Primary Care: Clinics in Office Practice, 1992
The past decade has seen many advances in the detection, characterization, and clinical applications of tumor markers. Although cancer screening applications have been limited by low disease prevalences in asymptomatic populations, tumor markers may be of diagnostic value in specific situations.
openaire   +2 more sources

Neuroendocrine Tumor Markers

1987
Neuroendocrine tumors arise from organs known to secrete neuroendocrine messengers, e.g. hormones or substances with paracrine activity, and/or to contain cells displaying neuroendocrine characteristics or activity. The term “neuro-endocrine” is used here to define the secretory products of the cells and tumors rather than their nature and ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy